Similar Search Results - EconBiz

Negotiating health and autonomy : data exclusivity, healthcare policies and access to pharmaceutical innovations

Menezes, Henrique Zeferino de; Paranhos, Julia; Torres, … - 2024

This paper analyzes the debate over the international dissemination of data exclusivity as a form of protection for clinical trial data. This is a critical demand for pharmaceutical companies seeking larger market shares and longer periods of monopoly in order to recover investments in research...

Persistent link: https://www.econbiz.de/10014637112

"We all have a responsibility to each other" : valuing racialised bodies in the neoliberal bioeconomy

Merz, Sibille; Williams, Ros - In: New political economy 23 (2018) 5, pp. 560-573

Persistent link: https://www.econbiz.de/10012113961

R&D internationalisation patterns in the global pharmaceutical industry : evidence from a network analytic perspective

Hu, Yuanjia; Scherngell, Thomas; Qiu, Lan; Wang, Yitao - In: Technology analysis & strategic management 27 (2015) 5, pp. 532-549

Persistent link: https://www.econbiz.de/10010517238

France's pharmaceutical industry in global value chains

Cezar, Rafael - In: Banque de France bulletin / Quarterly selection of articles 44 (2016/2017), pp. 51-63

Persistent link: https://www.econbiz.de/10011643971

Understanding the relationship between NTMs and FDI in Asia and the Pacific : a case study analysis

Taylor-Strauss, Heather; Chen, Jiaxin - 2019

Persistent link: https://www.econbiz.de/10012135496

New investment opportunities in pharmaceutical industry of Ukraine due to the spread of coronavirus disease (COVID-19)

Osos, Pavlo - In: Baltic Journal of Economic Studies 7 (2021) 5, pp. 153-158

Persistent link: https://www.econbiz.de/10013362224

Biomed Europa: after the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly

Florio, Massimo - 2020

Persistent link: https://www.econbiz.de/10012242700

Symbiotic relationship between a healthy population and a sustainable economy : financial performance of Julphar Gulf Pharmaceutical Industries

Olorogun, Lukman Ayinde; Yalciner, Kursat; Al Jaberi, … - In: International journal of economics and financial issues … 10 (2020) 2, pp. 148-155

Persistent link: https://www.econbiz.de/10012215086

Reorganizing value chains through foreign direct investment : Austria's pharmaceutical industry international expansion

Zeller, Christian; Hametner, Andreas - In: Competition & change : the journal of global business … 22 (2018) 5, pp. 529-557

Persistent link: https://www.econbiz.de/10011940917

Access to medicines after TRIPS : is compulsory licensing an effective mechanism to lower drug prices? ; a review of the existing evidence

Urias, Eduardo; Ramani, Shyama V. - In: Journal of International Business Policy : JIBP 3 (2020) 4, pp. 367-384

Persistent link: https://www.econbiz.de/10012405471

A service of the